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Abstract

Exposure to chronic stress, either repeated severe acute or moderate sustained stress, is one of the strongest
risk factors for the development of psychopathologies such as post-traumatic stress disorder and depression.
Chronic stress is linked with several lasting biological consequences, particularly to the stress endocrine
system but also affecting intermediate phenotypes such as brain structure and function, immune function, and
behavior. Although genetic predisposition confers a proportion of the risk, the most relevant molecular
mechanisms determining those susceptible and resilient to the effects of stress and trauma may be epigenetic.
Epigenetics refers to the mechanisms that regulate genomic information by dynamically changing the patterns
of transcription and translation of genes. Mounting evidence from preclinical rodent and clinical population
studies strongly support that epigenetic modifications can occur in response to traumatic and chronic stress.
Here, we discuss this literature examining stress-induced epigenetic changes in preclinical models and clinical
cohorts of stress and trauma occurring early in life or in adulthood. We highlight that a complex relationship
between the timing of environmental stressors and genetic predispositions likely mediate the response to
chronic stress over time, and that a better understanding of epigenetic changes is needed by further
investigations in longitudinal and postmortem brain clinical cohorts.
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Abstract
Exposure to chronic stress, either repeated severe acute or moderate sustained stress, is one of the strongest risk factors
for the development of psychopathologies such as post-traumatic stress disorder and depression. Chronic stress is linked
with several lasting biological consequences, particularly to the stress endocrine system but also affecting intermediate
phenotypes such as brain structure and function, immune function, and behavior. Although genetic predisposition confers
a proportion of the risk, the most relevant molecular mechanisms determining those susceptible and resilient to the effects
of stress and trauma may be epigenetic. Epigenetics refers to the mechanisms that regulate genomic information by dynamically changing the patterns of transcription and translation of genes. Mounting evidence from preclinical rodent and clinical
population studies strongly support that epigenetic modifications can occur in response to traumatic and chronic stress.
Here, we discuss this literature examining stress-induced epigenetic changes in preclinical models and clinical cohorts of
stress and trauma occurring early in life or in adulthood. We highlight that a complex relationship between the timing of
environmental stressors and genetic predispositions likely mediate the response to chronic stress over time, and that a
better understanding of epigenetic changes is needed by further investigations in longitudinal and postmortem brain clinical
cohorts.
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Introduction: Defining chronic stress
Exposure to chronic stressors across the human lifespan
can multiply an individual’s susceptibility to adverse medical conditions.1,2 In this article, chronic stress refers to (1)
a series of intense traumatic events such as accidents, physical assault, sexual assault, natural disasters, or combat
exposure, leading to psychopathologies such as complex
post-traumatic stress disorder (PTSD)3 or (2) nontraumatic but major events in life, whereby an individual
is exposed to sustained periods of stress, for example, caregiving, diﬃcult divorce, or a stressful work environment
leading to burnout.4 Chronic stress is a robust risk factor
for many medical conditions including cardiovascular disease, obesity, cancer, and immune disorders.5 It is also
highly linked with the development of a broad range of
psychiatric illnesses, including PTSD,6 major depressive
disorder,6 bipolar disorder,7 schizophrenia,7 anxiety disorders,8 substance abuse disorders,9 and addiction.10

Chronic stress and trauma are associated with several
lasting biological changes, particularly of the stress endocrine systems. For example, enduring stress and trauma
can lead to permanent changes in the structure of several
brain regions important for processing traumatic information (e.g. decreased somatosensory ﬁeld of genital
region after childhood sexual abuse),11 which might be
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an adaptive response to protect an individual from future
adversity.12,13 Interestingly, such adaptive mechanisms
appear to occur in all individuals exposed to similar
levels of stress or trauma, regardless of diagnostic outcome. Yet, only a fraction (20%) of people who have
experienced trauma go on to develop PTSD, while some
even experience post-traumatic growth.14 Additionally,
some individuals may not develop PTSD but other psychotic, anxiety, or aﬀective disorders—or a combination of
these—highlighting the heterogeneity of responses to
stress.15,16 Considering that the outcomes following
chronic stress exposure diﬀer greatly between individuals,
susceptibility to adversity resulting in psychopathology
might be determined by how eﬃciently an individual is
able to compensate for adversity at the molecular level.
In addition to genetic factors, some of the most relevant molecular mechanisms that may contribute to risk
or resilience to the eﬀects of stress and trauma are epigenetic. For example, DNA methylation proﬁles in
monozygotic twin pairs diverge as twins grow older,
with the diﬀerences between these genetically identical
individuals at least partially explained by diﬀering environmental exposures such as psychological stress.17
Further, in genome-wide association studies of stressrelated psychiatric disorders, single genetic variants
explain only a small proportion of disease risk and overall do not completely explain heritability.
Epigenetics refers to the mechanisms that regulate genomic information by dynamically changing the patterns
of transcription and translation of genes without altering
the underlying DNA sequence. This occurs by altering
the accessibility of DNA to transcriptional regulators
by: (i) post-translational modiﬁcations of histone proteins, (ii) the addition of chemical groups most commonly
at cytosine-phosphate-guanine (CpG) sites (e.g. methylation, hydroxymethylation, or other modiﬁcation), or (iii)
the binding of non-coding RNAs to speciﬁc sequences in
DNA. A growing body of evidence convincingly shows
that exposure to adversity can cause long-lasting epigenetic changes that lead to widespread alterations of gene
expression. Such alterations are observed in both brain
and peripheral tissues, indicating the widespread eﬀects
of stress throughout the whole organism. Epigenetics thus
provides a mechanism by which the environment can
have a global and lasting inﬂuence on the expression of
genes in an individual following stress exposure, with epigenetic processes believed to underlie associations of disease burden, environmental risk, and individual
phenotype.18 Elucidating the interface of gene and environment interactions can help lead to a better understanding of the development of psychopathologies, and how
they may be prevented or treated. In this review, we summarize preclinical and clinical research ﬁndings that support the existence of epigenetic modiﬁcations,
particularly DNA methylation, in response to conditions
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of chronic stress, highlighting the eﬀects of chronic and
traumatic stressors occurring at diﬀerent developmental
time points and how this may lead to vulnerability to
severe psychiatric disorders.

Epigenetics: Overview and Relevance
For environmental exposures to have lasting consequences on biological systems, alterations in gene transcription are required. This can occur by epigenetic
modiﬁcations that inﬂuence chromatin state, and thus
the accessibility of transcriptional machinery to regulatory regions such as gene promoters. Epigenetic modiﬁcations can be long lasting and can elicit either targeted or
genome-wide changes in gene expression by processes
including DNA methylation, post-translational histone
modiﬁcations, and non-coding RNA regulation. One of
the best understood epigenetic mechanisms involves the
methylation of cytosine (5-methylcytosine or 5mC) on
DNA, which occurs most abundantly at cytosines followed by guanine residues.19,20 In most instances, the
presence of methylated cytosine recruits repressor
complexes that modulate gene transcription by altering
chromatin and inhibiting accessibility of the promoter to
transcription factors and enhancers.21 Opposite eﬀects
have been reported in a site-speciﬁc manner, with inhibition of repressor binding or enhancement of methylationspeciﬁc enhancers.22,23 DNA methylation is considered to
be a stable epigenetic mark in post-mitotic cells, although
increasing evidence indicates that 5mC and 5-hydroxymethylcytosine (5hmC; the stable intermediary between
methylation and de-methylation) are dynamic, reversible,
and modiﬁable under certain conditions.20,21
Patterns of gene expression are also regulated by
histone modiﬁcations,24 which involve the covalent modiﬁcation of histone amino-terminal tails by, for instance,
methylation, acetylation, phosphorylation, or ubiquination among others. Histone modiﬁcations can alter the
level of chromatin condensation by either modifying
electrostatic charge or recruiting epigenetic ‘‘readers’’ or
‘‘erasers’’ that bind to histones to, respectively, increase
or decrease histone modiﬁcations. Epigenetic modiﬁcations to transcription and translation also extend to the
eﬀects of non-coding RNAs. These are short RNA
species that act post-transcriptionally to repress protein
synthesis, often by inducing degradation of mRNA targets.25 Patterns of epigenetic modiﬁcations are able to
elicit functional eﬀects that result in either gene expression repression or enhancement.
Several genetic variants are consistently shown to
interact with stress and trauma, with some of these eﬀects
long lasting. For example, in rodents exposed to stress
early in life—such as stress caused by changes in maternal
behavior—the epigenetic landscape of prominent ‘‘stress
genes’’ such as NR3C1 and CRH can be altered, with
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these eﬀects lasting into adulthood.26,27 Similar epigenetic
patterns have been observed in humans exposed to childhood maltreatment who develop a mood disorder or
PTSD later in life,28 and epigenetic alterations are
found in adults exposed to periods of chronic stress
including combat exposure,29 employment in a highstress environment,30 or a high lifetime stress load.31
Thus, chronic stress and trauma are environmental
exposures that can cause lasting epigenetic changes and
lead to the development of psychiatric pathology.
A number of studies, ranging from twin to molecular
genetic studies in large longitudinal cohorts, indicate that
the impact of adverse life events is likely moderated by
genetic variants, in the context gene  environment
(GE) interactions.32,33 The studies describe, however,
only statistical interactions by nature. Epigenetic marks
could provide a mechanism that may link how eﬀects of
genetic variants and environmental stimuli converge to
regulate gene transcription and in consequences change
in brain structure, endocrine responses, or behavior that
have been reported following stress exposure. Control of
gene expression by epigenetic modiﬁcations modulates
important cellular processes including neurogenesis,
neurotransmission, and synaptic plasticity, which are all
disrupted in conditions of sustained stress.34,35 Such
eﬀects may inﬂuence an organism at not only a molecular
level but also at circuitry and systemic levels.
Some evidence suggests that epigenetic modiﬁcations
may be sustained during cell division and possibly transmitted across generations.32,33 This is important in the
context of chronic stress exposure, as progressive but sustained epigenetic changes may be cumulative and could
even be a result of prior chronic stress exposure in the
parent. Several studies based on periods of deprivation,
such as the Swedish famine,36 Dutch Hunger winter,37
Montreal ice storm,38,39 and the Holocaust,40 provide
some support for intergenerational transmission of
traits through epigenetics, through investigating the oﬀspring of parents who were subject to this trauma.
However, the strongest evidence for epigenetic transgenerational inheritance comes from animal studies of
paternal transmission, which show that the oﬀspring of
chronically stressed adult male mice are more vulnerable
to stressful stimuli, have dysregulated stress responses,
and altered hypothalamic-pituitary-adrenal (HPA) axis
activity compared to control mice.41,42 It has been
hypothesized that these apparently heritable eﬀects may
be underpinned by an epigenetic mechanism transmitted
via sperm.43 However, these studies remain highly controversial in light of currently accepted models that epigenetic modiﬁcations are erased during meiosis.44,45
Further, it remains unclear whether transgenerational
stress-related behavioral alterations are truly epigenetic
imprinting or a post-conception consequence of change
in the uterine milieu or parental behavior.
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Several caveats of epigenetic studies should be mentioned here. Firstly, human and animal studies investigating stress-induced epigenetic modiﬁcations for the most
part report associative or correlational eﬀects, rather than
causal eﬀects. They also often do not elucidate the mechanism by which the epigenetic change is induced nor its
functional consequence. Secondly, while DNA methylation levels for some CpGs are correlated across brain and
blood or saliva and blood,46–48 most are not. However,
speciﬁc genetic variants or environments that cause the
release of hormones with system-wide eﬀects may have
common eﬀects on DNA methylation across tissues that
may only diﬀer in magnitude.49,50 There is also some evidence that overall, DNA methylation derived from
buccal cells may be more closely related to brain, as
both tissues are derived from the ectoderm. However,
compared to the low relatedness between brain and
whole blood, the improvements are small.48
Additionally, in complex tissues such as the brain, epigenetic mechanisms also diﬀer according to brain regions,
sub-brain regions, and cell types.51 Thus, results from
epigenetic studies in peripheral blood or saliva may
have to be interpreted with great care with regard to
their reﬂection of causal eﬀects on disease risk.
Methylation-wide approaches have the advantage of
giving a broad picture of the methylome, but there are
some important considerations for each method. While
array-based methods are cost-eﬃcient and technically
robust, data pre-processing—including normalization
and batch-correction—can have strong inﬂuences on the
data, especially if small changes are expected. Several
publications thus advocate that studies using array technologies should focus on results that survive multiple correction methods.52–54 Further, currently used methylation
arrays focus on promoter regions, with lower coverage in
enhancers that appear critical for stress-related impact.
Sequencing approaches may therefore seem optimal;
however, these methods are also subject to limitations.
Firstly, DNA methylation does not vary at the majority
of CpGs in a given tissue and so untargeted sequencingbased methods may result in lower sensitivity with less
reads per CpG generated, reducing cost-eﬃciency.
Importantly, a bias can also be observed with bisulﬁte
conversion.55 Direct sequencing of unmodiﬁed DNA
using single molecule real-time sequencing methods
might be a superior approach and is being developed by
a number of companies. In addition, there is a push for
the development of arrays that focus on additional CpGs,
and other bases not covered by current array
technologies.56
An important requirement of the ﬁeld is now to thoroughly catalog which epigenetic modiﬁcations occur in
response to which types of stress (e.g. nature vs. timing
vs. length of stress) in which diﬀerent cell-types and tissues, and how this characterizes risk proﬁles and
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psychopathologies. The development of targeted, highly
sensitive DNA methylation detection methods will propel
this eﬀort.

Epigenetic Mechanisms Early in Life and
Lasting Effects of Early Life Adversity
Stress occurring early in development can cause dramatic
eﬀects on physiology and behavior.57 In this context,
early epigenetic changes in the brain are important factors. Changing methylation patterns have been observed
in promoter regions of many genes across healthy brain
development, especially in the human dorsolateral prefrontal cortex, a brain region which is late to mature
and highly implicated in neuropsychiatric disorders.58
Speciﬁcally, a switch from de-methylation to increased
methylation of many genes at the genome level characterize the transition from fetal to childhood time points.59
It is likely that interruption of normal developmental epigenetic patterns by stress or trauma early in life may alter
epigenetic trajectories and lead to the development of
psychopathology later in life.
A growing number of associations support the link
between stress or trauma exposure and the occurrence of
widespread epigenetic changes. For example, common
genetic variants in DNMT genes appear to moderate the
eﬀects of daily life stressors and perinatal adversity on
paranoid ideation.60 DNMTs are enzymes required for
the methylation of neurogenic genes, also suggesting that
exposure to chronic stressors early in life might disturb
brain function in adulthood.61 Large methylation changes
at the beginning of the lifespan, particularly on genes
implicated in developing severe psychiatric conditions
(e.g. DLG4, DRD2, NOS1, NRXN1, and SOX10) may
also indicate vulnerability to the eﬀects of stress and psychiatric disorders by epigenetic mechanisms.59

Prenatal Adversity
Even from the ﬁrst possible window of stress exposure—in utero—organisms may be susceptible to epigenetic programming which persists into adult life (Table
1(a)).80 In particular, epigenetic diﬀerences in key genes
that regulate the HPA axis are reported in people exposed
to prenatal adversity.80 These eﬀects are hypothesized to
last into adulthood by epigenetic re-programming of the
HPA axis.57 For example, women and their children
exposed to trauma or chronic stress from the war in the
Democratic Republic of Congo reportedly had diﬀerential patterns of methylation on genes associated with
stress; these included hyper-methylation of CRH and
NR3C1 in cord blood and CRH, FKBP5, and CRHBP
in the placenta.68,63 Yehuda et al.40 additionally showed
that FKBP5, a gene involved in glucocorticoid receptor
(GR) and stress sensitivity, was hyper-methylated in

Chronic Stress
Holocaust survivors, while hypo-methylation of the
same CpGs occurred in the oﬀspring. An additional
cohort examining pregnant mothers exposed to the
Quebec Icestorm of 1998, prenatal stress caused a widespread change to the epigenetic landscape of oﬀspring,
particularly in genes related to immune function.38,39
Considering the unequivocal role of the GR in stress
responsivity, several studies have focused on epigenetic
modiﬁcations of NR3C1 in response to various types of
prenatal stress. For example, in those exposed to intimate
partner violence during the prenatal period, DNA methylation was increased in the NR3C1 1F promoter region.62
Additionally, in oﬀspring of mothers pregnant during the
Holocaust genocide, hyper-methylation of the NR3C1
exon 1F promoter methylation was observed much later
in life, speciﬁcally in oﬀspring who had one parent suffering from PTSD.64 Methylation was, however,
decreased for oﬀspring with two parents who had
PTSD, presenting what could be a complex mechanism
of potential maternal and paternal eﬀects of PTSD on
epigenetic regulation of NR3C1, although it is possible
that epigenetic changes occurring in oﬀspring were an
eﬀect of living with a parent with PTSD rather than genocide exposure. Together with evidence from animal studies,81 hyper-methylation of the NR3C1 promoter
appears to be a robust epigenetic modiﬁcation occurring
in response to stress early in life. Altogether, there appear
to be strong and widespread eﬀects of prenatal stress on
the epigenetic regulation of the stress signaling system
that lasts into adulthood, although the intergenerational
mechanisms for some genes (e.g. FKBP5 and CRH) need
to be further explored perhaps using animal models.

Childhood Adversity Assessed During Childhood
and Adolescence
Considering that certain epigenetic markers occurring
during development may set an individual on a path for
developing psychopathology later in life, some studies
have aimed to examine methylation patterns in the
brains of those exposed to chronic stress during childhood (Table 1(b)). Some of the eﬀects seen with prenatal
stress are also seen with stress during childhood. In suicide completers exposed to childhood abuse, hypermethylated sites were observed in the NR3C1 variant 1
promoter region at a non-canonical binding site for nerve
growth factor–induced protein A. This was further associated with down-regulated expression of the NR3C1 1F
splice variant in the hippocampus.82 While these localized
ﬁndings for epigenetic regulation of the GR are quite
interesting, the eﬀects of childhood adversity is likely epigenome-wide, as methylation proﬁles in the hippocampus
of suicide completers with a history of childhood abuse
were reportedly bidirectional and dynamic, with both
methylation and de-methylation of numerous genes
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Type of trauma

Pregnant mothers
exposed to chronic
stress and/or traumatic war-related
stress

Pregnant mothers during
genocide

Pregnant mothers during
genocide

Pregnant mothers during
a severe ice storm

Pregnant mothers during
a severe ice storm

Mulligan et al.63

Yehuda et al.64

Yehuda et al.65

Cao-Lei et al.66

Cao-Lei et al.67

(a) Prenatal stress
Radtke et al.62
Intimate partner domestic
violence

References

36 children of mothers
who subjectively rated
the consequences of
the ice storm as positive or negative.

32 Holocaust survivors
and 22 adult offspring,
8 comparable parents
and 9 comparable
offspring
34 children (assessed
twice, age 8 and 13)
whose mothers were
exposed to the ice
storm while pregnant.

80

25 mother-newborn
dyads

24 mothers and children:
8 prenatal exposure to
maternal stress, 16 no
prenatal exposure to
maternal stress

Sample size/relevant
diagnosis

T cells from peripheral
blood mononuclear
cells

T cells from peripheral
blood mononuclear
cells and saliva

Peripheral blood

Peripheral blood

Maternal peripheral blood
and umbilical cord
blood

Peripheral blood

Tissue type

Illumina Infinium
HumanMethylation450K
BeadChip Array

Illumina Infinium
HumanMethylation450K
BeadChip Array,
Validation by bisulfite
pyro-sequencing

Bisulfite sequencing

Bisulfite sequencing

Sodium bisulfite sequencing

Sodium bisulfite sequencing

Method

CpGs in 1564 different genes and 408
biological pathways (prominently
associated with immune function)
were differentially methylated in
adolescents from positive and negative maternal groups. A large proportion of differentially methylated
CpGs and affected pathways overlapped with those associated with
objective measures of prenatal
maternal stress, as published in CaoLei et al., 2014.

Hyper-methylation of the FKBP5 CpGs
close to intron 7 glucocorticoid
response elements in Holocaust survivors, hypo-methylation in Holocaust
offspring.
Objective hardship, but not subjective
distress, was correlated with DNA
methylation in 957 genes, predominately in pathways related to immune
function.

Increased DNA methylation for one
PTSD parent; decreased for two
PTSD parents.

Significant correlation between maternal
prenatal stress, newborn birth weight
and newborn methylation in the
NR3C1 promoter.

Increased DNA methylation of the
NR3C1 promoter.

Findings

(continued)

Genome-wide methylation study

Genome-wide methylation study

FKBP5 intron 7

NR3C1 exon 1F
promoter

NR3C1 exon 1F
promotor

NR3C1 exon 1F
promoter

Genome-wide methylation study or target
genes

Table 1. Summary of studies examining epigenetic modifications in response to early life adversity during (a) prenatal time points (b) childhood time points or (c) in adults with a
history of early life adversity.
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Pregnant mothers
exposed to chronic
stress and/or traumatic war-related
stress

Type of trauma

388 pre-adolescent children (11 to 13 years)
of African American
ethnicity.

45 individuals with/without diagnosis of MDD
and/or a history of
childhood adversity
468 adolescents (mean
age 16 years)

Childhood abuse (physical, sexual, emotional), neglect,
witnessed domestic
violence)

Cumulative exposure to
low socioeconomic
status

Childhood trauma before
age 13

Various types of stress
(perinatal stress,
stressful life events and
traumatic youth
experiences)

Beach et al.71

Houtepen
et al.72

van der Knaap
et al.31

28 10-year-old bullied
children and 28 of
their non-bullied
monozygotic twins
94 maltreated and 96
healthy non-traumatized children

24 mother-newborn
dyads

Sample size/relevant
diagnosis

Weder et al.70

(b) Childhood stress
Ouellet-Morin
Children exposed to
et al.69
bullying

Kertes et al.68

References

Table 1. Continued

Peripheral blood

Peripheral blood

Peripheral blood

Saliva

Buccal cells

Neonatal cord blood,
placenta, maternal
blood

Tissue type

Bisulfite conversion and
quantitative mass
spectrometry

Illumina Infinium
HumanMethylation450K
BeadChip Array

Illumina Infinium
HumanMethylation450K
BeadChip Array

Illumina Infinium
HumanMethylation450K
BeadChip Array

Sequenom EpiTYPER
platform

Illumina Infinium
HumanMethylation450K
BeadChip Array

Method

Increased DNA methylation of 11 CpGs
in the promoter of NR3C1 exon 1D
after stressful life events and after
exposure to traumatic youth
experiences.

Methylation of Kit ligand gene (KITLG)
strongly mediated the relationship
between childhood trauma and cortisol stress reactivity.

No effect on SLC6A4 methylation across
16 CpG residues, and no effect of the
5-HTTLPR genotype. In females only,
one cpG site showed increased
methylation in assoication with
cumulative low socioeconomic status.

Methylation in ID3, GRIN1, and TPPP
were genome-wide significant predictors of depression. Maltreated and
control children had significantly different methylation profiles of BDNF,
NR3C1 and FKBP5

Increased SERT DNA methylation
observed in bullied children compared to their non-bullied twin.

Cord blood: increased methylation in CRH
was associated with chronic stress
and war trauma. Placenta: reduced
methylation of NR3C1 associated
with war trauma and chronic stress.
War-trauma was also associated wiht
methylation of CRH, FKBP5, CRHBP.
Maternal blood: NR3C1 methylation was
associated with war trauma. NR3C1,
CRH, CRHBP, NR3C1, FKBP5 were
nominally associated with war trauma
and/or stress.

Findings

NR3C1

(continued)

Genome-wide methylation study

SLC6A4

Genome-wide methylation study

SLC6A4

Targeted analysis
CRH, CRHBP,
MR3C1, FKBP5

Genome-wide methylation study or target
genes
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73

Children exposed to
extended severe
adversity before the
age of 43 months

Type of trauma
49 individuals assessed at
ages 15 years compared to adoptees
exposed to stress <6
months or no early life
stress.

Sample size/relevant
diagnosis

Adults adopted in the first
few months after birth
into middle class
families, with psychological dysfunction due
to unresolved loss or
trauma

Childhood abuse leading
to PTSD

Severe psychiatric disorders with history of
childhood adversity

van IJzendoorn
et al.75

Smith et al.76

Perroud et al.28
101 Borderline personality disorder, 99 major
depression, 15 major
depression with PTSD

110 (25 PTSD þ childhood abuse, 25 PTSD
no childhood abuse,
26 conrols with childhood abuse, 34 controls wihtout
childhood abuse)

143 adoptees

(c) Adults with a history of early life adversity
Wankerl et al.74 Healthy young adults with 133
recent life stress/
trauma and/or a childhood and prenatal
trauma

Kumsta et al.

References

Table 1. Continued

Peripheral blood

Peripheral blood

EBV transformed
lymphoblast cell lines

Peripheral blood

Buccal cell samples

Tissue type

Bisulfite pyrosequencing

Illumina Human
Methylation27
BeadChip

Bisulfite conversion and
quantitative mass
spectrometry

Bisulfite pyrosequencing

Illumina Infinium
HumanMethylation450K
BeadChip Array

Method

Severity and number of type of childhood sexual abuse correlated with
NR3C1 methylation

Increased global methylation PTSD vs
controls. Five gene promoters were
differentially methylated (TPR,
CLEC9A, APC5, ANXA2, and TLR8)
in PTSD compared to controls, but
no CpGs were associated with childhood abuse.

Higher methylation of the SLC6A4 promoter was associated with increased
risk of unresolved responses to loss
or other trauma in participants carrying a single-nucleotide polymorphism (SNP) in SLC6A4, usually with
protective associations. The risk allele
predicted more unresolved loss or
trauma in participants with lower
levels of methylation.

No effects of prenatal, early or recent
life stress/trauma on the mean
SLC6A4 methylation levels and no
correlation between methylation and
SERT mRNA expression. Hypermethylation at 2 CpGs were significantly associated with mRNA
expression and prenatal stress/
trauma, but not recent life stress/
trauma.

A differentially methylated region spanning 9 CpG sites in the promotorregulatory region of the CYP2E1 gene
was identified, and associated with
deprivation related clinical markers of
impaired social cognition.

Findings

NR3C1

(continued)

Genome-wide methylation study

SLC6A4

SLC6A4

CYP2E1

Genome-wide methylation study or target
genes

Illumina Human
Methylation 450K array
Peripheral blood
169 (32 PTSD affected, 77
PTSD unaffected)
Individuals with history of
childhood abuse, with
and without PTSD
Mehta et al.79

Note. PTSD: posttraumatic stress disorder; EBV: Epstein–Barr virus; MDD: major depressive disorder; SERT: serotonin transporter; CTQ: childhood trauma questionnaire.

Genome-wide methylation study

FKBP5

DNA demethylation in a functional
glucocorticoid response element in
FKBP5 in the presence of FKBP5
functional polymoprhism increased
risk to psychiatric disorder later in
life.
Distinct (95%) gene expression profiles
seen in PTSD groups with a history of
childhood abuse compared to those
with no history of childhood abuse,
which appeared to be mediated by
changes of DNA methylation.
Bisulfite pyrosequencing
76 (30  2 childhood
trauma, 46 no childhood trauma)
PTSD, physical and sexual
abuse during childhood (CTQ)
Klengel et al.78

Peripheral blood

Genome-wide methylation study
Methylation patterns of gene promoters
between those with childhood
adversity and those without were
distinct.
Custom 400K eArray
(Agilent Technologies)
Hippocampal tissue
25 with history of childhood abuse, 16 control subjects
Male suicide completers
with a history of
childhood adversity
Labonté et al.77

References

Type of trauma

Tissue type

Method

Findings

Genome-wide methylation study or target
genes
Sample size/relevant
diagnosis

Table 1. Continued
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observed.77 Hyper-methylation at promoters of genes
that encode ribosomal RNAs were also reported in
abused suicide victims compared to controls, possibly
indicating widespread eﬀects as ribosomal RNA methylation and transcription directly aﬀect cellular function
and synaptic plasticity associated with fear memory and
cognitive dysfunction.83
Additional studies have examined epigenome-wide
methylation diﬀerences in children exposed to childhood
maltreatment or trauma (e.g. physical abuse, sexual
abuse, neglect, deprivation, emotional abuse, witnessed
domestic violence) compared to non-traumatized individuals.72,70,73 Weder et al.70 reported that methylation
patterns at the genes ID3, GRIN1, and TPPP were
genome-wide signiﬁcant predictors of depression later in
life. Maltreated children relative to control children had
signiﬁcantly altered methylation proﬁles at the BDNF,
NR3C1, and FKBP5 genes, which are all genes that
respond to stress exposure and implicated in psychopathology. In a sample of English and Romanian adoptees,
individuals chronically exposed to severe deprivation
before 43 months of age showed hyper-methylation
across nine CpGs spanning the promoter of the
CYP2E1 gene at the age of 15 years. Hyper-methylation
of CYP2E1 was also associated with impaired social cognition, a clinical marker of deprivation.73 In addition,
Houtepen et al.72 reported that methylation of the KIT
ligand gene KITLG, which is involved in haematopoiesis
and the cortisol response, strongly mediated the relationship between childhood trauma and cortisol stress
responsivity. This would suggest a link between stress
occurring early in life and epigenetic modiﬁcations lasting
into adulthood that may increase risk to psychopathology in adulthood by altering the responsivity of the
stress hormone system.
Another group of studies suggest epigenetic changes in
peripheral tissue at the SLC6A4 locus and the consequences of stress in older children.74 For example, in a
study by Beach et al.,71 children aged 11–13 years with
cumulative exposure to low socio-economic status
showed hyper-methylation at the SLC6A4 locus. A similar eﬀect was observed in a second study, with increased
methylation of SLC6A4 in bullied twins at age 10 compared to their non-bullied monozygotic twins.69

Effects of Childhood Adversity Lasting Into Adulthood
The studies assessing epigenetic modiﬁcations that occur
in response to prenatal and childhood adversity strongly
support evidence that stress during development leads to
epigenetic modiﬁcations that likely inﬂuence gene expression later in life,84 especially in genes involved in stress
responsivity. During these critical developmental time
points, changes in expression of ‘‘stress genes’’ might
alter an individual’s ability to cope with stress and set

Matosin et al.
the stage for vulnerability to psychopathology later in
life. Some groups have assessed clinical populations of
individuals who were exposed to childhood adversity
and who developed PTSD in adulthood (Table 1(c)).
These investigations collectively support that childhood
adversity is associated with speciﬁc epigenetic modiﬁcations in those that develop a psychiatric disorder.
Other groups assessing childhood abuse in adults with
severe psychiatric disorders have focused on stress candidate genes. In one report, the severity and number of
exposures to childhood sexual abuse was positively correlated with NR3C1 hyper-methylation in subjects with
severe psychiatric disorders including PTSD and comorbid major depressive disorder.28 In another cohort of
subjects with PTSD exposed to childhood adversity,
DNA de-methylation was found to be decreased in a
glucocorticoid response element in FKBP5, speciﬁcally
in the presence of an FKBP5 functional polymorphism
that increased risk to psychiatric disorder later in
life.78 These data mirror the ﬁndings from prenatal
adversity studies, supporting the inference that such epigenetic modiﬁcations to the stress system occur in
response to early life adversity and may last into adulthood to increase development of a severe psychiatric
condition.

Stress and Trauma During Adulthood
In addition to early life adversity, experiencing extreme
levels of stress or trauma during adulthood can also
increase the risk of developing severe psychiatric conditions. However, the mechanism is likely distinct between
these two scenarios. Firstly, early life experiences occur
during a particularly sensitive time, where environmental
inﬂuences can have strong eﬀects on the brain and body,
causing molecular, structural, and behavioral disturbances that stay with the individual into adulthood.
While severe stress or trauma occurring exclusively in
adulthood can also result in detrimental biological consequences, body systems are already matured thus possibly
causing a diﬀerent cascade of events. In fact, we could
show that patients suﬀering from PTSD with either only
adult trauma or a combination of child abuse and adult
trauma had distinct gene expression and DNA methylation signatures in peripheral blood.79

Epigenetic Changes in Preclinical Stress Models
Adult animals exposed to severe acute or non-traumatic
chronic stress have shown various epigenetic changes
attributable to stress exposure. Considering a hallmark
of PTSD is the formation of fear memories, many studies
have used fear learning paradigms for exploring the consequences of trauma exposure.85 These studies have
shown that fear conditioning induces the expression
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of DNA methyl-transferases type 3A and 3B (Dnmt3A/
3B), leading to altered DNA methylation at genes that
are important for memory formation and plasticity (e.g.
Reelin, Pp1, and Bdnf).20,86–88Others have highlighted a
role for histone acetylation in long-term fear recall and
spatial memory. For example, environmental enrichment
was shown to improve memory deﬁcits in the brain; this
was associated with up-regulation of histone acetylation
and activity of histone deacetylases, which modulate synaptic plasticity via altering the expression of genes including glutamate receptor subunits and Bdnf.89–91 These
ﬁndings have linked stress to brain plasticity and behavior, by long-lasting epigenetic modiﬁcations.
Clear epigenetic changes have also been observed in
animal models of chronic stress.92 One of the primary
ﬁndings from genome-wide epigenetic studies in rodent
models is that chronic stress induces widespread alterations in histone modiﬁcations, particularly in the hippocampus.93 For example, chronic variable stress caused
alterations to the expression of transcripts that encode
histones or recruit histone writers and erasers.94,95 With
regard to methylation, associations between chronic
defeat stress and Dnmt3A expression was shown in the
nucleus accumbens, which is a brain region that plays a
signiﬁcant role in processing of aversion, motivation, and
rewards.96 Interventions (mainly pharmacological such as
antidepressants), which induce H3K9 di- or tri- methylation, have been shown to promote resilience to stress and
depressive-like behavior.97,98 Chronic stress in adult animals also exerts epigenetic modiﬁcations to key genes
involved in HPA-axis signaling,99 such as Crh,100,101
Hsp90,102 and Bdnf.103,104
Epigenetic changes in response to severe and chronic
stress can clearly be associated with stress exposure in
animal models. While this is more complex in human
studies, clinical studies complement these ﬁndings, supporting the existence of lasting epigenetic eﬀects in
response to trauma or prolonged stress within both the
central and peripheral nervous systems. In the following
sections, we will discuss examples of epigenetic changes
observed in humans exposed to acute traumatic events or
non-traumatic chronic stress in adulthood.

Epigenetic Changes Due to Acute Traumatic
Events in Adults
Studies examining the epigenetic eﬀects of traumatic
events in adults have either used genome-wide methylation approaches or focused on known ‘‘stress genes.’’
Most of these studies are cross-sectional studies of
individuals examined post-trauma, derived from
epidemiological cohorts. Additionally, most examine epigenetic proﬁles in peripheral tissues such as blood and
saliva, which may be useful for biomarker identiﬁcation
(Table 2).
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PTSD due to traumatic
event(s)

PTSD due to traumatic
event(s)

PTSD due to traumatic
event(s)

PTSD due to traumatic
event(s)

PTSD: accumulative
exposure to traumatic effects after
initial trauma

Smith et al.76

Ressler et al.106

Uddin et al.107

Koenen et al.108

Type of trauma

Uddin et al.105

References

23 PTSD-affected, 77
PTSD-unaffected

23 PTSD affected, 77
PTSD unaffected

107 PTSD

25 PTSD with history of
childhood trauma 25
PTSD without history
of childhood trauma,
26 controls with and 24
controls without childhood truama

23 PTSD affected, 77
PTSD unaffected

Sample size

Peripheral blood

Peripheral blood

Peripheral blood

Peripheral blood

Peripheral blood

Tissue type

Pyrosequencing

Illumina Human
Methylation27
BeadChip

Illumina Human
Methylation27
BeadChip

Illumina Human
Methylation27
BeadChip

Illumina Human
Methylation27
BeadChip

Method
Genes associated with immune
function were un-methylated
and negatively correlated with
traumatic burden in PTSD
Global increase in methylation
levels in PTSD vs controls.
CpG sites in TPR, CLEC9A,
APC5, ANXA2, and TLR8
were differentially methylated
in subjects with PTSD. A CpG
site in NPFFR2 was associated
with total life stress after
adjustment for multiple
testing.
A SNP in a putative oestrogen
response element within
ADCYAP1R1, rs2267735,
predicted PTSD and symptoms in females; the SNP also
associated with fear discrimination and ADCYAP1R1
expression in human brain;
methylation of ADCYAP1R1
was associated with PTSD in
peripheral blood
Risk of lifetime PTSD was markedly higher in patients with
higher MAN2C1 methylation
with greater exposure to
PTEs
Increased risk for PTSD in cases
with reduced DNA methylation levels

Findings

SLC6A4

(continued)

33 candidate genes
associated with
PTSD (based on
RNA expression)

ADCYAP1R1

Genome-wide
methylation study

Genome-wide
methylation study

Target (genomewide methylation
study or genes)

Table 2. Summary of studies examining epigenetic changes in response to trauma in adulthood, with a focus on genome-wide methylation studies and candidate gene studies in PTSD.
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PTSD due to combat
exposure

PTSD due to traumatic
event(s)

PTSD due to traumatic
event(s)

PTSD due to combat
exposure

PTSD due to traumatic
event(s)

Veterans with PTSD
received who prolonged exposure
(PE) psychotherapy

Chang et al.110

Norrholm et al.111

Rusiecki et al.112

Uddin et al.113

Yehuda et al.114

Type of trauma

Rusiecki et al.109

References

Table 2. Continued

PTSD PE responders (n ¼
8), defined by no longer
meeting diagnostic criteria for PTSD, and
non-responders (n ¼ 8)

23 PTSD affected, 77
PTSD unaffected

74 post-deployment
PTSD, 74 no PTSD

98 PTSD, 172 no PTSD

62 PTSD, 258 controls

75 with post-deployment
PTSD, 75 without postdeployment PTSD

Sample size

Peripheral blood
lymphocytes

Peripheral blood

Peripheral blood

Peripheral blood

Peripheral blood

Peripheral blood

Tissue type

Targeted bisulfite
sequencing

Illumina Human
Methylation27
BeadChip

Illumina Human
Methylation27
BeadChip
Pyrosequencing

Illumina Human
Methylation27
BeadChip

Pyrosequencing

Method
Hyper-methylation of Line1 in
non-PTSD group pre- vs postdeployment; Hypo-methylated Line1 in PTSD vs nonPTSD post-deployment. Alu
was hyper-methylated in cases
vs controls pre-deployment
Risk allele carriers (9R) showed
increased risk of lifetime
PTSD only in conjunction with
high promoter methylation of
SLC6A3
Increased COMT promoter
methylation associated with
impaired fear inhibition
Reduced methylation of H19 and
IL18 in those resilient to
PTSD after deployment. Postdeployment PTSD individuals
increased IL8 methylation
after deployment.
Methylation in genes predominately related to nervous
system function and risk to
develop PTSD was modified
by low socioeconomic status.
Methylation NR3C1 exon 1F
assessed at pre-treatment
predicted treatment outcome,
but was not significantly
altered in responders or nonresponders at post-treatment
or follow-up. Methylation of
the FKBP5 gene (FKBP51)
exon 1 promoter region did
not predict treatment
response, but decreased in
association with recovery.

Findings

(continued)

NR3C1 and FKBP5
promoters

Genome-wide
methylation study

IGF2, H19, IL8, IL16,
IL18

COMT

SLC6A3

LINE1 and Alu

Target (genomewide methylation
study or genes)
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PTSD due to combat
exposure

PTSD due to combat
exposure

Bam et al.118

Bam et al.119

PTSD due to combat
exposure
Subjects with pre and
postincidental
trauma with and
without PTSD
PTSD due to combat
exposure

Type of trauma

PTSD due to combat
exposure (high
exposure)

115

Almli et al.117

Yehuda et al.29

Sipahi et al.116

Vukojevic et al.

References

Table 2. Continued

76 controls and 23 PTSD

76 controls and 23 PTSD

63 with severe PTSD and
84 without PTSD

122 PTSD

30 PTSD and 30 controls

152 PTSD

Sample size

Peripheral blood
mononuclear
cells

Peripheral blood
mononuclear
cells

Peripheral blood

Peripheral blood

Peripheral blood

Saliva

Tissue type

Illumina
HumanMethylation27 BeadChip

Illumina
HumanMethylation27 BeadChip

Illumina Human
Methylation
450K Beadchip

Pyrosequencing

Pyrosequencing

Pyrosequencing

Method

Reduced DNA methylation of
the NR3C1 promoter in
PTSD
A genome-wide significant SNP
(rs717947) was identified and
associated with PTSD symptoms. The SNP was then discovered to be as a
methylation quantitative trait
loci which was also associated
with altered DLPFC activation
in response to fearful faces.
Global DNA methylation level
did not differ significantly
between control and PTSD.
The promoters of several
individual immune function
genes were differentially
methylated and/or were more
highly expressed.
326 genes and 190 miRNAs
were had altered expression
levels in PTSD. DNA methylation of differentially
expressed genes showed a
trend toward differences
between control and PTSD.

Increased DNA methylation in
men
Differential DNA methylation
levels of DNMTs in cases vs
controls

Findings

(continued)

Genome-wide
methylation study

Genome-wide
methylation study

Genome-wide
methylation study

NR3C1 exon 1F
promoter

NR3C1 exon 1F
promoter
DNMT1, DNMT3A,
DNMT3B,
DNMT3L

Target (genomewide methylation
study or genes)

SKA2 methylation at
the rs7208505
locus
DNA methylation of rs7208505
was associated with reduced
thickness in of several cortical
areas; methylation was also
positively associated with
PTSD symptom severity.

Genome-wide
methylation study
No differences with adjusted
significance for DNA methylation were found.

Peripheral blood

Affymetrix Gene
Chip Human
Exon 1.0 ST
Array
Illumina Human
Methylation
450K Beadchip
Peripheral blood

PTSD due to combat
exposure
Sadeh et al.121

12 PTSD, 12 without
PTSD but with the
similar level of trauma
exposure
200 trauma exposed veterans (þ145 with
structural brain image
information)
PTSD due to traumatic
event(s)
Chen et al.120

References

Type of trauma

Sample size

Tissue type

Method

Findings

Target (genomewide methylation
study or genes)
Table 2. Continued

Genome-wide methylation studies support the existence of epigenetic diﬀerences between trauma-exposed
individuals with PTSD compared to psychiatrically
healthy controls, with cross-sectional diﬀerences in
DNA methylation observed in cohorts from Atlanta76
and Detroit.105 These studies have shown that epigenetic
diﬀerences were able to diﬀerentiate those who have
developed PTSD compared to those who did not. Later
studies from longitudinal cohorts of US military personnel exposed to combat-trauma further suggested signiﬁcant diﬀerences in global methylation in PTSD patients
relative to controls,109,112 particularly in genes involved in
immune105,112 and nervous system function.113 Such longitudinal studies allow the dissection of separate contributions of trauma exposure versus disease development,
which is not readily possible in cross-sectional studies.
A larger number of studies have investigated DNA
methylation of speciﬁc candidate genes, including genes
involved in the regulation of the stress hormone axis.
Here, studies have focused on NR3C1 (exon 1F) and
FKBP5. In one study from saliva, NR3C1 methylation
at CpG site 42 was increased in men with PTSD;115 however, in another study from blood, methylation at CpG
site 28 was reduced in PTSD.29 The diﬀerences may represent tissue- or CpG site-speciﬁc diﬀerences, variability
in the trauma type or its timing, or sex and age.122 In an
earlier study, veterans exposed to severe war trauma
underwent prolonged exposure therapy and were assessed
pre- and post-exposure treatment.114 The study showed
that methylation of NR3C1 exon 1F locus pre-treatment
predicted treatment outcome, but methylation was not
signiﬁcantly diﬀerent in responders or non-responders
to the exposure therapy at post-treatment or followup.114 Methylation of the FKBP5 exon 1 promoter also
did not predict treatment response, but was decreased in
association with recovery.114 This study provides preliminary evidence that these methylation markers may
underlie the severity of PTSD symptoms, and that reversal of the methylation changes may tract with eﬀective
therapeutic intervention.
The immune system is one of the main eﬀectors of
HPA axis activity, and in turn, changes in methylation
are associated with total life stress, PTSD diagnosis, and
a history of childhood abuse.76 Epigenetic eﬀects to genes
involved in immune function are a consistent ﬁnding in
PTSD, supporting that sustained sympathetic nervous
system activity in response to trauma stimulates
immune system activation. For example, DNA methylation of genes associated with immune function was found
to be largely negatively correlated with traumatic burden
in PTSD.105 Others consistently reported altered methylation of pro-inﬂammatory cytokines, such as interleukin
12 and 18, in individuals with PTSD compared to those
without.76,112,118 Analysis of histone and DNA methylation markers suggest that widespread epigenetic changes
13
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in PTSD, including those in immune genes, might occur
by alterations to DNMT1118 or miRNAs,119 which are
molecules that induce and maintain global methylation
patterns.
In addition to identiﬁcation of epigenetic markers
associated with diagnostic outcomes, some studies have
begun to additionally assess associations of DNA methylation to endophenotypes of psychiatric disease, including
neuroimaging phenotypes. For example, a genome-wide
signiﬁcant variant, rs717947 (positioned in an inter-genic
locus at chromosome 4p15), was identiﬁed as a methylation quantitative trait locus associated with altered cortical activation in response to fearful faces.123 Another
study showed associations between the methylation
status, a polymorphic site in the 3’UTR of the SKA2
gene—involved in mitosis—with reduced thickness of
several cortical areas and symptom severity in PTSD.121
Finally, methylation in peripheral blood samples of
ADCYAP1R1, a gene involved in regulating the cellular
stress response, was associated with PTSD diagnosis and
symptom severity, speciﬁcally in females.106 Collectively,
these studies support that epigenetic changes in response
to stress may ‘‘mediate’’ particular stress phenotypes.
Several studies have now investigated DNA methylation in the context of GE including candidate genes
involved in neurotransmitter turn-over such as SLC6A4
(encoding the serotonin transporter SERT), SLC6A3
(encoding the dopamine transporter), and COMT
(encoding enzymes that degrade neurotransmitters such
as dopamine). In one study, reduced SLC6A4 methylation levels were associated with more traumatic events
and increased risk for PTSD, only in those carrying a
speciﬁc SLC6A4 risk allele genotype, while higher methylation appeared protective against the development of
PTSD.108 In an independent cohort, individuals with
PTSD carrying the SLC6A3 9-repeat allele were at
higher risk to PTSD when also having higher methylation
in the SLC6A3 promoter locus.110 Finally, increased
COMT promoter methylation was associated with
impaired fear inhibition in individuals with PTSD carrying the COMT met/met genotype; this genotype has been
extensively associated with a range of psychiatric conditions and phenotypes.124 These studies suggest that epigenetic changes following trauma often only occur in the
context of speciﬁc genetic variation and that genetic risk
may only manifest with concomitant epigenetic changes.

Epigenetic Changes Due to Sustained Non-traumatic
Stress in Adults
It is well established that chronic stress results in adverse
health outcomes, but only a handful of studies exist that
explore the association of non-traumatic chronic stress
(e.g. work- and lifestyle-related stresses) with epigenetic
changes (Table 3). To our knowledge, there are no

Chronic Stress
genome-wide analyses examining diﬀerences in epigenetic
marks in populations exposed to non-traumatic chronic
stress. One study used LINE-1 as a proxy for global
methylation, but no diﬀerences in LINE-1 methylation
were found in subjects exposed to recent life stressors compared to controls.127 A few other studies have examined
epigenetic changes to candidate genes within populations
of individuals exposed to occupational chronic stress.
For example, in workers employed in the manufacturing industry in environments of high or low stress, Myaki
et al.126 examined DNA methylation of the tyrosine
hydroxylase (TH) gene. TH encodes an enzyme involved
in synthesis of catecholamines including serotonin, dopamine, epinephrine, and norepinephrine, which are all
altered in rodent models of chronic stress.128,129
Methylation of CpG sites in the TH gene and the ﬂanking
50 region was signiﬁcantly higher in individuals exposed to
high occupational stress compared to individuals working
in low-stress environments.126 The same group also
explored altered methylation in the BDNF gene based on
a priori hypothesis that this gene is also epigenetically
aﬀected in a preclinical model of PTSD.103 Slightly
increased methylation was observed across the whole
gene in subjects exposed to high-stress compared to lowstress environments, although the groups showed no difference in promoter-speciﬁc methylation.125 Work-related
stress in this study was assessed using a self-administered
questionnaire, with methylation levels of groups from the
lowest and highest job-strain quartiles compared.125
Another group focused on methylation of the SLC6A4
gene due to some evidence that methylation diﬀerences in
this gene occur in stress-induced psychopathologies such
as PTSD (discussed in section ‘‘Epigenetic changes due to
acute traumatic events in adults’’) and depression.130 In
shift-working nurses in high-stress work environments
compared to those in low-stress work environments,
ﬁve CpG sites in the promoter region of SLC6A4 were
examined.30 Higher methylation across the tested
SLC6A4 CpGs was found in those working in a highcompared to low-stress environment, and this was associated with burnout and the perception of stress.30
Further investigation into the eﬀects of non-traumatic
chronic stressors, such as work-related stress or caregiving, is limited. This is likely as the length and severity of
non-traumatic stress is often not as well deﬁned as traumatic stress, and many confounding factors make the
results of these studies less clear. These studies might
also be confounded by the number of stressors, which
might have an additive eﬀect, and further studies are
needed to disentangle this.

Future Directions and Conclusions
Studies examining epigenetic changes in response to stress
are providing a potential opportunity to identify
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Japanese
manufacturers

Healthy adult males
chronic lifestyle
stressors

Myaki et al.126

Duman et al.127

Shift-working
nurses with
burnout or
depression

Type of trauma

Manufacturing
workers

30

Song et al.125

Alasaari et al.

References

105 (18 to 77 years old)

180 (quartiles of 90 with
lowest and highest job
strain with bottom and
top quartiles
compared)

180 (quartiles of 90 with
lowest and highest job
strain with bottom and
top quartiles
compared)

24 high stress, 25 low
stress

Sample size

Peripheral blood
mononuclear
cells

Saliva leukocytes

Saliva leukocytes

Peripheral blood
leukocytes

Tissue type

Global methylation
(LINE-1; PyroMark)
and Sequenom
EpiTyper MassArray
of SLC6A4 locus

Illumina Human
Methylation27
BeadChip

Illumina Human
Methylation27
BeadChip

Direct sanger bisulfite
sequencing and
Methylation 450k
Beadchip

Method

Findings
Nurses with stress had lower promoter methylation at all CpG
residues compared to those with
low-stress. Methylation levels
were not associated with burnout/depression.
Slightly increased methylation across
the all tested CpGs in BDNF in
high-stress compared to lowstress occupational environments. No group-specific differences in promoter methylation.
Methylation of TH CpG sites and
the flanking 5’ region were higher
in individuals exposed to high
occupational stress compared to
individuals working in low-stress
environments.
Chronic stress correlated with
global DNA methylation, which
appeared to be driven by a 5serotonin-transporter-linked
polymorphic region genotype
effect.

Table 3. Summary of studies examining epigenetic changes in response to non-traumatic chronic stress exposure in adulthood.

LINE-1 and
SLC6A4

TH

BDNF

SLC6A4

Target genes
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vulnerable and resilient populations (e.g. based on combined prior exposure, other environmental factors and
genetics) and biomarkers of risk for those exposed to
chronic stress. However, additional studies of how diﬀerent types and lengths of stress lead to epigenetic changes
are required as well as of combined eﬀects of positive and
negative environments. The ﬁeld of epigenetics is in fact
relatively young, and studies examining epigenetic modiﬁcations in conditions of chronic stress are limited. One
example is that, to the best of our knowledge, no studies
have examined epigenetic modiﬁcations in postmortem
brain samples derived from individuals with PTSD.
Additionally, human studies are also limited in that
there are few longitudinal studies with repetitive measurements from the same individual at diﬀerent time points
relative to the stress exposure, and currently, many studies published are cross-sectional and underpowered.
Changes to gene expression by epigenetic modiﬁcations
are prominent gene and environment interactions that are
an important aspect of future chronic stress and trauma
research. Particularly, epigenetic patterns in peripheral
tissues may act as biomarkers that may serve as sentinels
of when genetic predisposition followed by environmental exposure leads to trajectories of risk to develop psychiatric symptoms and syndromes. For mechanistic
understanding, tissue speciﬁcity of these epigenetic
changes must be addressed and understood. Overall,
more research in this area will lead to a better understanding of stress-induced epigenetic eﬀects and mechanisms as well as their potential moderation, allowing for
their therapeutic exploitation and the development of
new interventions and treatments.
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